YAHOO FINANCE CHARTBOOK 44 charts that explain markets and the economy right now Mexico - Delayed Quote • MXN UNITED THERAPEUTICS CORP (UTHR.MX) Follow Compare 6,902.22 0.00 (0.00%) At close: October 9 at 9:10:50 AM CST Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for UTHR.MX 1D 5D 0.00% 1M 0.00% 3M 0.00% 6M 0.00% YTD 0.00% 1Y 0.00% 5Y 0.00% All 0.00% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: UTHR.MX View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Drugmakers Show Restraint on Price Increases in New Trump Era United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference We Ran A Stock Scan For Earnings Growth And United Therapeutics (NASDAQ:UTHR) Passed With Ease United Therapeutics Announces Successful World’s First UKidney Transplant The 3.8% return this week takes United Therapeutics' (NASDAQ:UTHR) shareholders five-year gains to 314% United Therapeutics Corporation to Present at the UBS Global Healthcare Conference United Therapeutics Corporation Reports Third Quarter 2024 Financial Results United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024 Profitable Biotech In Buy Zone As Earnings Approach